Trials / Unknown
UnknownNCT04069845
A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin
A Registry Study on the Risk Factors of Interstitial Pneumonia in Lymphoma Patients Treated With Liposomal Doxorubicin
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
This study is to evaluate the incidence of interstitial pneumonia in lymphoma patients treated with liposomal doxorubucin. The treatment response and other adverse events will also be studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | liposomal doxorubicin | intravenous liposomal doxorubicin |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2021-08-01
- Completion
- 2021-08-30
- First posted
- 2019-08-28
- Last updated
- 2021-03-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04069845. Inclusion in this directory is not an endorsement.